Cloroqualone
From Self-sufficiency
| 120px | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(2,6-Dichlorophenyl)-2-ethyl-4-quinazolinone | |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Biological half-life | ? |
| Excretion | ? |
| Identifiers | |
| CAS Number | 25509-07-3 |
| ATC code | none |
| PubChem | CID 63338 |
| DrugBank | ? |
| ChemSpider | 57005 |
| Chemical data | |
| Formula | C16H12Cl2N2O |
| Molar mass | 319.185[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Cloroqualone is an analogue of methaqualone developed in the 1980s and marketed mainly in France and some other European countries. It has sedative and antitussive properties, and was sold either alone or in combination with other ingredients as a cough medicine.[1] Cloroqualone has weaker sedative properties than methaqualone and was sold for its useful cough-suppressing effects, but was withdrawn from the French market in 1994 because of concerns about its potential for abuse and overdose.
See also
References
| 40x30px | This sedative-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Sedatives
- Organochlorides
- Quinazolinones
- Sedative stubs
- 2Fix
